Although analysis of a larger patient cohort may be required to conclusively address this point, the high proliferative status constitutively observed in Non responder breast tumors by Ki-67 staining[32], has been previously associated with drug-resistant disease and poor outcome[33]. The gene discussed is MKI67; the disease is breast neoplasm.